Acadia Pharmaceuticals (ACAD) SEC News Jan. 13, 2026, 20:58 UTC (99% Neutral) Acadia Pharmaceuticals (ACAD) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 7:49 p.m. 📋 Acadia Pharmaceuticals (ACAD) - Financial Results Filing Date: 2026-01-13 Accepted: 2026-01-13 15:58:51 Event Type: Financial Results Event Details: Acadia Pharmaceuticals (ACAD) Reports the reporting period Financial Results Acadia Pharmaceuticals (ACAD) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: Not disclosed 📊 Key Financial Metrics: Metric Value 💼 Business Developments: No business developments data available. Structured Data: Company Name: Acadia PharmaceuticalsTicker Symbol: ACAD
📋 Acadia Pharmaceuticals (ACAD) - Financial Results
Filing Date: 2026-01-13
Accepted: 2026-01-13 15:58:51
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: